RS

Renu Srivastava

Active Director Designated Partner DIN 05009643
DIN 05009643 First appointment Sep 2010 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Renu Srivastava

Data last updated:

Renu Srivastava is a Designated Partner at Laxum Pharmaceuticals Llp (since 2010). The company operates in Chemicals.

DIN 05009643
Primary Designation Designated Partner
Industry Chemicals
First Appointment 27 Sep 2010
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Sep 20102010Active

Board colleagues of Renu Srivastava

NameDINCompanyDesignation
Jiwankumar Anantkumar Sinha03017358Laxum Pharmaceuticals LlpDesignated Partner
Leena Jiwankumar Sinha03017918Laxum Pharmaceuticals LlpDesignated Partner
Mamta Rajesh Kumar05009577Laxum Pharmaceuticals LlpDesignated Partner
Rakesh Kumar05010026Laxum Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Laxum Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Renu Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Srivastava

Renu Srivastava currently holds 1 directorship: Laxum Pharmaceuticals Llp (Designated Partner, since 27 Sep 2010).

Renu Srivastava was first appointed on 27 Sep 2010 as Designated Partner at Laxum Pharmaceuticals Llp.

The current boards of Renu Srivastava's companies include Jiwankumar Anantkumar Sinha (Laxum Pharmaceuticals Llp), Leena Jiwankumar Sinha (Laxum Pharmaceuticals Llp), Mamta Rajesh Kumar (Laxum Pharmaceuticals Llp), Rakesh Kumar (Laxum Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available